Patients Benefit From Genetics‐Guided Coumarin Anticoagulant Therapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-6535|96|1|15-17

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.96, Iss.1, 2014-07, pp. : 15-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Corrigendum: Patients Benefit From Genetics‐Guided Coumarin Anticoagulant Therapy

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 3, 2014-09 ,pp. : 397-397

John Wiley & Sons Inc

Access to resources Recommend Favorite

Lung cancer patients with an abnormal gene benefit from targeted therapy

By  

CANCER, Vol. 119, Iss. 20, 2013-10 ,pp. : 3582-3582

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anticoagulant Therapy

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 35, Iss. 4, 1987-04 ,pp. : 369-369

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rationalized DNA sequencing-based protocol for genotyping patients receiving coumarin therapy

By Rakicevic Ljiljana B.   Kusic-Tisma Jelena S.   Kovac Mirjana K.   Backovic Dragana T.   Radojkovic Dragica P.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 73, Iss. 6, 2013-09 ,pp. : 523-527

Informa Healthcare

Access to resources Recommend Favorite

Which Panic Disorder Patients Benefit from Which Treatment: Cognitive Therapy or Antidepressants?

By  

Psychotherapy and Psychosomatics, Vol. 76, Iss. 3, 2007-04 ,pp. : 154-161

Karger

Access to resources Recommend Favorite